UK, China Research Teams Partner on $31M Epigenetics Study | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Research teams in the UK and China have launched a new £20 million ($30.7 million) partnership to study epigenetic factors in thousands of pairs of twins in order to learn why many identical twins do not develop the same diseases as one another, King's College London said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.